Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2302-2306, May 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eads, C. A.
Right arrow Articles by Laird, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eads, C. A.
Right arrow Articles by Laird, P. W.
[Cancer Research 59, 2302-2306, May 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

CpG Island Hypermethylation in Human Colorectal Tumors Is Not Associated with DNA Methyltransferase Overexpression1

Cindy A. Eads, Kathleen D. Danenberg, Kazuyuki Kawakami, Leonard B. Saltz, Peter V. Danenberg and Peter W. Laird2

Departments of Surgery [C. A. E., P. W. L.] and Biochemistry and Molecular Biology [C. A. E., K. D. D., K. K., P. V. D., P. W. L.], University of Southern California, School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California 90033, and Memorial Sloan Kettering Cancer Center, New York, New York 10021-6094 [L. B. S.]

The molecular basis of aberrant hypermethylation of CpG islands observed in a subset of human colorectal tumors is unknown. One potential mechanism is the up-regulation of DNA (cytosine-5)-methyltransferases. Recently, two new mammalian DNA methyltransferase genes have been identified, which are referred to as DNMT3A and DNMT3B. The encoded proteins differ from the predominant mammalian DNA methyltransferase DNMT1 in that they have a substantially higher ratio of de novo to maintenance methyltransferase activity. We have used a highly quantitative 5' nuclease fluorogenic reverse transcription-PCR method (TaqMan) to analyze the expression of all three DNA methyltransferase genes in 25 individual colorectal adenocarcinoma specimens and matched normal mucosa samples. In addition, we examined the methylation patterns of four CpG islands [APC, ESR1 (estrogen receptor), CDKN2A (p16), and MLH1] to determine whether individual tumors show a positive correlation between the level of DNA methyltransferase expression and the frequency of CpG island hypermethylation. All three methyltransferases appear to be up-regulated in tumors when RNA levels are normalized using either ACTB (ß-actin) or POLR2A (RNA pol II large subunit), but not when RNA levels are normalized with proliferation-associated genes, such as H4F2 (histone H4) or PCNA. The frequency or extent of CpG island hypermethylation in individual tumors did not correlate with the expression of any of the three DNA methyltransferases. Our results suggest that deregulation of DNA methyltransferase gene expression does not play a role in establishing tumor-specific abnormal DNA methylation patterns in human colorectal cancer.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
L. S. Kristensen and L. L. Hansen
PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment
Clin. Chem., August 1, 2009; 55(8): 1471 - 1483.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
A. R. Sepulveda, D. Jones, S. Ogino, W. Samowitz, M. L. Gulley, R. Edwards, V. Levenson, V. M. Pratt, B. Yang, K. Nafa, et al.
CpG Methylation Analysis--Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology
J. Mol. Diagn., July 1, 2009; 11(4): 266 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Y. Sanders, A. Pardo, M. Selman, G. J. Nuovo, T. O. Tollefsbol, G. P. Siegal, and J. S. Hagood
Thy-1 Promoter Hypermethylation: A Novel Epigenetic Pathogenic Mechanism in Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 610 - 618.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Gao, Y. Kondo, L. Shen, Y. Shimizu, T. Sano, K. Yamao, A. Natsume, Y. Goto, M. Ito, H. Murakami, et al.
Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas
Carcinogenesis, October 1, 2008; 29(10): 1901 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-W. Cheng, H. Pincas, M. D. Bacolod, G. Schemmann, S. F. Giardina, J. Huang, S. Barral, K. Idrees, S. A. Khan, Z. Zeng, et al.
CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 6005 - 6013.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
C. B. Yoo, J. C. Chuang, H.-M. Byun, G. Egger, A. S. Yang, L. Dubeau, T. Long, P. W. Laird, V. E. Marquez, and P. A. Jones
Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice
Cancer Prevention Research, September 1, 2008; 1(4): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic
Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection
Nucleic Acids Res., April 1, 2008; 36(7): e42 - e42.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. S. Wang, D. J. Smiraglia, Y.-Z. Wu, S. Ghosh, J. S. Rader, K. R. Cho, T. A. Bonfiglio, R. Nayar, C. Plass, and M. E. Sherman
Identification of Novel Methylation Markers in Cervical Cancer Using Restriction Landmark Genomic Scanning
Cancer Res., April 1, 2008; 68(7): 2489 - 2497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Y. Jung, E. M. Poole, J. Bigler, J. Whitton, J. D. Potter, and C. M. Ulrich
DNA Methyltransferase and Alcohol Dehydrogenase: Gene-Nutrient Interactions in Relation to Risk of Colorectal Polyps
Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 330 - 338.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Fabbri, R. Garzon, A. Cimmino, Z. Liu, N. Zanesi, E. Callegari, S. Liu, H. Alder, S. Costinean, C. Fernandez-Cymering, et al.
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
PNAS, October 2, 2007; 104(40): 15805 - 15810.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. B. Yoo, S. Jeong, G. Egger, G. Liang, P. Phiasivongsa, C. Tang, S. Redkar, and P. A. Jones
Delivery of 5-Aza-2'-Deoxycytidine to Cells Using Oligodeoxynucleotides
Cancer Res., July 1, 2007; 67(13): 6400 - 6408.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
S. Ogino, T. Kawasaki, G. J. Kirkner, P. Kraft, M. Loda, and C. S. Fuchs
Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample
J. Mol. Diagn., July 1, 2007; 9(3): 305 - 314.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Fonsatti, H. J.M. Nicolay, L. Sigalotti, L. Calabro, L. Pezzani, F. Colizzi, M. Altomonte, M. Guidoboni, F. M. Marincola, and M. Maio
Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2'-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications
Clin. Cancer Res., June 1, 2007; 13(11): 3333 - 3338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. T. Agoston, P. Argani, A. M. De Marzo, J. L. Hicks, and W. G. Nelson
Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex
Am. J. Pathol., May 1, 2007; 170(5): 1585 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas
Cancer genetics of epigenetic genes
Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
N. Widodo, C. C. Deocaris, K. Kaur, K. Hasan, T. Yaguchi, K. Yamasaki, T. Sugihara, T. Ishii, R. Wadhwa, and S. C. Kaul
Stress Chaperones, Mortalin, and Pex19p Mediate 5-Aza-2' Deoxycytidine-Induced Senescence of Cancer Cells by DNA Methylation-Independent Pathway
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 246 - 255.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Gu, D. Berman, C. Lu, I. I. Wistuba, J. A. Roth, M. Frazier, M. R. Spitz, and X. Wu
Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non-Small Cell Lung Cancer
Clin. Cancer Res., December 15, 2006; 12(24): 7329 - 7338.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
S. Ogino, T. Kawasaki, G. J. Kirkner, M. Loda, and C. S. Fuchs
CpG Island Methylator Phenotype-Low (CIMP-Low) in Colorectal Cancer: Possible Associations with Male Sex and KRAS Mutations
J. Mol. Diagn., November 1, 2006; 8(5): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, G. Walsh, D. D. Liu, J. J. Lee, and L. Mao
Expression of {Delta}DNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non-Small Cell Lung Cancer.
Cancer Res., September 1, 2006; 66(17): 8361 - 8366.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S Ogino, M Cantor, T Kawasaki, M Brahmandam, G J Kirkner, D J Weisenberger, M Campan, P W Laird, M Loda, and C S Fuchs
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
Gut, July 1, 2006; 55(7): 1000 - 1006.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
S. Ogino, T. Kawasaki, M. Brahmandam, M. Cantor, G. J. Kirkner, D. Spiegelman, G. M. Makrigiorgos, D. J. Weisenberger, P. W. Laird, M. Loda, et al.
Precision and Performance Characteristics of Bisulfite Conversion and Real-Time PCR (MethyLight) for Quantitative DNA Methylation Analysis
J. Mol. Diagn., May 1, 2006; 8(2): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Schatz, J. Distler, K. Berlin, and M. Schuster
Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.
Nucleic Acids Res., January 1, 2006; 34(8): e59 - e59.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. J. Weisenberger, M. Campan, T. I. Long, M. Kim, C. Woods, E. Fiala, M. Ehrlich, and P. W. Laird
Analysis of repetitive element DNA methylation by MethyLight
Nucleic Acids Res., December 2, 2005; 33(21): 6823 - 6836.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Zhang, C. R. Martins, Z. B. Fansler, K. L. Roemer, E. A. Kincaid, K. S. Gustafson, D. F. Heitjan, and D. P. Clark
DNA Methylation in Anal Intraepithelial Lesions and Anal Squamous Cell Carcinoma
Clin. Cancer Res., September 15, 2005; 11(18): 6544 - 6549.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. T. Agoston, P. Argani, S. Yegnasubramanian, A. M. De Marzo, M. A. Ansari-Lari, J. L. Hicks, N. E. Davidson, and W. G. Nelson
Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer
J. Biol. Chem., May 6, 2005; 280(18): 18302 - 18310.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ushijima, N. Watanabe, K. Shimizu, K. Miyamoto, T. Sugimura, and A. Kaneda
Decreased Fidelity in Replicating CpG Methylation Patterns in Cancer Cells
Cancer Res., January 1, 2005; 65(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Chen, C. Rocken, C. Lofton-Day, H.-U. Schulz, O. Muller, N. Kutzner, P. Malfertheiner, and M. P.A. Ebert
Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis
Carcinogenesis, January 1, 2005; 26(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Kim, B. N. Trinh, T. I. Long, S. Oghamian, and P. W. Laird
Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells
Nucleic Acids Res., October 27, 2004; 32(19): 5742 - 5749.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K Baker, Y Zhang, C Jin, and J R Jass
Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?
J. Clin. Pathol., October 1, 2004; 57(10): 1089 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Kaneda, K. Wakazono, T. Tsukamoto, N. Watanabe, Y. Yagi, M. Tatematsu, M. Kaminishi, T. Sugimura, and T. Ushijima
Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers
Cancer Res., September 15, 2004; 64(18): 6410 - 6415.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. O. Hoque, S. Begum, O. Topaloglu, C. Jeronimo, E. Mambo, W. H. Westra, J. A. Califano, and D. Sidransky
Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer
Cancer Res., August 1, 2004; 64(15): 5511 - 5517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Fackler, M. McVeigh, J. Mehrotra, M. A. Blum, J. Lange, A. Lapides, E. Garrett, P. Argani, and S. Sukumar
Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer
Cancer Res., July 1, 2004; 64(13): 4442 - 4452.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Widschwendter, K. D. Siegmund, H. M. Muller, H. Fiegl, C. Marth, E. Muller-Holzner, P. A. Jones, and P. W. Laird
Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen
Cancer Res., June 1, 2004; 64(11): 3807 - 3813.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. C. Cheng, D. J. Weisenberger, F. A. Gonzales, G. Liang, G.-L. Xu, Y.-G. Hu, V. E. Marquez, and P. A. Jones
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Mol. Cell. Biol., February 1, 2004; 24(3): 1270 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. E. Cottrell, J. Distler, N. S. Goodman, S. H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin
A real-time PCR assay for DNA-methylation using methylation-specific blockers
Nucleic Acids Res., January 13, 2004; 32(1): e10 - e10.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. Feltus, E. K. Lee, J. F. Costello, C. Plass, and P. M. Vertino
Predicting aberrant CpG island methylation
PNAS, October 14, 2003; 100(21): 12253 - 12258.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Girault, S. Tozlu, R. Lidereau, and I. Bieche
Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas
Clin. Cancer Res., October 1, 2003; 9(12): 4415 - 4422.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Hibi, M. Koike, H. Nakayama, S. Fujitake, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao
A Cancer-prone Case with a Background of Methylation of p16 Tumor Suppressor Gene
Clin. Cancer Res., March 1, 2003; 9(3): 1053 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Brabender, H. Usadel, R. Metzger, P. M. Schneider, J. Park, D. Salonga, D. D. Tsao-Wei, S. Groshen, R. V. Lord, N. Takebe, et al.
Quantitative O6-Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome
Clin. Cancer Res., January 1, 2003; 9(1): 223 - 227.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. M. Sirotnak, Y. She, F. Lee, J. Chen, and H. I. Scher
Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer
Clin. Cancer Res., December 1, 2002; 8(12): 3870 - 3876.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. C. Lorincz, D. Schubeler, S. R. Hutchinson, D. R. Dickerson, and M. Groudine
DNA Methylation Density Influences the Stability of an Epigenetic Imprint and Dnmt3a/b-Independent De Novo Methylation
Mol. Cell. Biol., November 1, 2002; 22(21): 7572 - 7580.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. Zochbauer-Muller, J. D. Minna, and A. F. Gazdar
Aberrant DNA Methylation in Lung Cancer: Biological and Clinical Implications
Oncologist, October 1, 2002; 7(5): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. O. Toyooka, S. Toyooka, A. Maitra, Q. Feng, N. C. Kiviat, A. Smith, J. D. Minna, R. Ashfaq, and A. F. Gazdar
Establishment and Validation of Real-Time Polymerase Chain Reaction Method for CDH1 Promoter Methylation
Am. J. Pathol., August 1, 2002; 161(2): 629 - 634.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. N. Trinh, T. I. Long, A. E. Nickel, D. Shibata, and P. W. Laird
DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair
Mol. Cell. Biol., May 1, 2002; 22(9): 2906 - 2917.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Z. Khokhar, A. F. Y. Lam, V. W. Rusch, and F. M. Sirotnak
Despite some expression of folate receptor {alpha} in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated
J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Eads, A. E. Nickel, and P. W. Laird
Complete Genetic Suppression of Polyp Formation and Reduction of CpG-Island Hypermethylation in ApcMin/+Dnmt1-Hypomorphic Mice
Cancer Res., March 1, 2002; 62(5): 1296 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Liang, M. F. Chan, Y. Tomigahara, Y. C. Tsai, F. A. Gonzales, E. Li, P. W. Laird, and P. A. Jones
Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements
Mol. Cell. Biol., January 15, 2002; 22(2): 480 - 491.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Usadel, J. Brabender, K. D. Danenberg, C. Jeronimo, S. Harden, J. Engles, P. V. Danenberg, S. Yang, and D. Sidransky
Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer
Cancer Res., January 1, 2002; 62(2): 371 - 375.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kawakami, D. Salonga, J. M. Park, K. D. Danenberg, H. Uetake, J. Brabender, K. Omura, G. Watanabe, and P. V. Danenberg
Different Lengths of a Polymorphic Repeat Sequence in the Thymidylate Synthase Gene Affect Translational Efficiency but Not Its Gene Expression
Clin. Cancer Res., December 1, 2001; 7(12): 4096 - 4101.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. Jeronimo, H. Usadel, R. Henrique, J. Oliveira, C. Lopes, W. G. Nelson, and D. Sidransky
Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma
J Natl Cancer Inst, November 21, 2001; 93(22): 1747 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. F. Chan, R. van Amerongen, T. Nijjar, E. Cuppen, P. A. Jones, and P. W. Laird
Reduced Rates of Gene Loss, Gene Silencing, and Gene Mutation in Dnmt1-Deficient Embryonic Stem Cells
Mol. Cell. Biol., November 15, 2001; 21(22): 7587 - 7600.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Osanai, W. Ichikawa, Y. Takagi, H. Uetake, Z. Nihei, and K. Sugihara
Expression of Pyrimidine Nucleoside Phosphorylase (PyNPase) in Colorectal Cancer
Jpn. J. Clin. Oncol., October 1, 2001; 31(10): 500 - 505.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Z. Khokhar, Y. She, V. W. Rusch, and F. M. Sirotnak
Experimental Therapeutics with a New 10-Deazaaminopterin in Human Mesothelioma: Further Improving Efficacy through Structural Design, Pharmacologic Modulation at the Level of MRP ATPases, and Combined Therapy with Platinums
Clin. Cancer Res., October 1, 2001; 7(10): 3199 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-H. Lin, S.-Y. Hsieh, I-S. Sheen, W.-C. Lee, T.-C. Chen, W.-C. Shyu, and Y.-F. Liaw
Genome-wide Hypomethylation in Hepatocellular Carcinogenesis
Cancer Res., May 1, 2001; 61(10): 4238 - 4243.
[Abstract] [Full Text]


Home page
BloodHome page
M. Toyota, K. J. Kopecky, M.-O. Toyota, K.-W. Jair, C. L. Willman, and J.-P. J. Issa
Methylation profiling in acute myeloid leukemia
Blood, May 1, 2001; 97(9): 2823 - 2829.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Eads, R. V. Lord, K. Wickramasinghe, T. I. Long, S. K. Kurumboor, L. Bernstein, J. H. Peters, S. R. DeMeester, T. R. DeMeester, K. A. Skinner, et al.
Epigenetic Patterns in the Progression of Esophageal Adenocarcinoma
Cancer Res., April 1, 2001; 61(8): 3410 - 3418.
[Abstract] [Full Text]


Home page
BloodHome page
S.-i. Mizuno, T. Chijiwa, T. Okamura, K. Akashi, Y. Fukumaki, Y. Niho, and H. Sasaki
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
Blood, March 1, 2001; 97(5): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Kawakami, J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, A. S. Fleisher, J. M. Abraham, D. G. Beer, et al.
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
J Natl Cancer Inst, November 15, 2000; 92(22): 1805 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Eads, R. V. Lord, S. K. Kurumboor, K. Wickramasinghe, M. L. Skinner, T. I. Long, J. H. Peters, T. R. DeMeester, K. D. Danenberg, P. V. Danenberg, et al.
Fields of Aberrant CpG Island Hypermethylation in Barrett's Esophagus and Associated Adenocarcinoma
Cancer Res., September 1, 2000; 60(18): 5021 - 5026.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Esteller, A. Sparks, M. Toyota, M. Sanchez-Cespedes, G. Capella, M. A. Peinado, S. Gonzalez, G. Tarafa, D. Sidransky, S. J. Meltzer, et al.
Analysis of Adenomatous Polyposis Coli Promoter Hypermethylation in Human Cancer
Cancer Res., August 1, 2000; 60(16): 4366 - 4371.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
R. T. Cormier and W. F. Dove
Dnmt1N/+ Reduces the Net Growth Rate and Multiplicity of Intestinal Adenomas in C57BL/6-Multiple Intestinal Neoplasia (Min)/+ Mice Independently of p53 but Demonstrates Strong Synergy with the Modifier of Min 1AKR Resistance Allele
Cancer Res., July 1, 2000; 60(14): 3965 - 3970.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, C. Blake, D. Shibata, P. V. Danenberg, and P. W. Laird
MethyLight: a high-throughput assay to measure DNA methylation
Nucleic Acids Res., April 15, 2000; 28(8): e32 - e.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S.-W. Choi and J. B. Mason
Folate and Carcinogenesis: An Integrated Scheme1-3
J. Nutr., January 1, 2000; 130(2): 129 - 132.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Kuismanen, M. T. Holmberg, R. Salovaara, P. Schweizer, L. A. Aaltonen, A. de la Chapelle, M. Nystrom-Lahti, and P. Peltomaki
Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers
PNAS, October 26, 1999; 96(22): 12661 - 12666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Detich, S. Ramchandani, and M. Szyf
A Conserved 3'-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity
J. Biol. Chem., June 29, 2001; 276(27): 24881 - 24890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.